Cambrex extends Ontak contract
Cambrex Bio Science has won an additional five-year contract to manufacture Ontak, a biopharmaceutical product developed by Ligand Pharmaceuticals.
Archives for October 14, 2003
Safety syringes booming
The market for retractable syringes designed to prevent needlestick injuries is set for explosive growth and could expand nearly seven-fold by 2006, according to a new report.
Vaccines from rabbits' milk
France's BioProtein Technologies, a biotechnology company specialising in the production of therapeutic proteins in the milk of transgenic rabbits, has extended its biomanufacturing services to include recombinant vaccine production.
Elan extends J&J collaboration
Ireland's Elan Corp has signed up another heavyweight partner - Janssen - for its NanoCrystals technology, designed to improve the solubility of drug compounds.